Comprehensive Guide to Vitamins by Dr. James Meschino - HTML preview

PLEASE NOTE: This is an HTML preview only and some elements such as links or page numbers may be incorrect.
Download the book in PDF, ePub, Kindle for a complete version.

Vitamin B6 - Pyridoxine, Pyridoxal and Pyridoxamine

Introduction

Vitamin B6 is involved in the formation of body proteins, red blood cells, anti-inflamatory prostaglandins, the synthesis of brain neurotransmitters and proper function of the immune system. It is required by more than 60 different enzymes.

Absorption and Metabolism

Vitamin B6 is rapidly absorbed in the upper small intestine. After absorption, all three forms of Vitamin B6 are converted to pyridoxal phosphate, the active coenzyme form. Although pyridoxal phosphate is found in all the tissues of the body, there is no real storage. It is excreted in the urine mainly as pyridoxic acid, along with small amounts of pyridoxal and pyridoxamine.

Functions

Unlike Vitamins B1, B2, B3, biotin, and panthothenic acid, Vitamin B6 does not participate directly in energy metabolism.

Rather it is a coenzyme involved in protein metabolism, prostaglandin synthesis and immune modulation.

Protein and Amino Acid Metabolism

Transamination: e.g., conversion of alanine to pyruvate for energy production and gluconeogenesis.

Decarboxylation: in the synthesis of neurotransmitters (e.g., serotonin, norepinephrine, histamine (the vasodilator)):

histadine conversion to histamine.

Transsulfuration: transfer of a sulfur group from one amino acid to form another (i.e., serine converted to cysteine).

Side-chain transfers: conversion of methionine to cysteine.

Hemoglobin synthesis

Conversion of tryptophan to niacin.

Formation of Prostaglandins series one and three.

Myelin sheath formation around nerve cells.

Immune system support.



Recommended Daily Allowance (RDA) Vitamin B6

Classic Vitamin B6 Deficiency

Deficiency of Vitamin B6 is characterized by:

1.Depression
2.Convulsions (especially in children)
3.Glucose Intolerance (B6 is needed for glucose release from liver)
4.Nausea and vomiting
5.Anemia (microcytic)
6.Impaired nerve function, peripheral neuritis, altered mobility
7.Cracking of lips and tongue
8.Seborrhea or eczema

Vitamin B6 Supplementation

Supplementation appears to be beneficial for a number of health concerns as Vitamin B6 plays a vital role in the multiplication of all cells. It is, therefore, of critical importance to a healthy pregnancy, proper immune system function, mucous membranes, skin, and red blood cells. These tissues have a greater than average need for Vitamin B6 due to the high replication rate of these cells.1

Lowers Homocysteine (Decreasing Heart Disease Risk)

Supplementation with folic acid and Vitamin B12. Vitamin B6 also helps to lower homocysteine levels by converting homocysteine to cystathionine; as a coenzyme for cystathionine B-synthase enzyme. A recent trial included 100 mg of Vitamin B6 in patients with hyperhomocysteinemia (plus 500 mcg of folic acid) and demonstrated a successful lowering of blood homocysteine levels.2

Decreased Platelet Aggregation

Supplementation of 5 mgs per kg of body weight demonstrates a 41 percent to 48 percent reduction in platelet aggregation.3,4 However, be aware that neurotoxicity can occur at intakes above 100-150 mg per day.

Reduces Inflammatory Conditions

Vitamin B6 supplementation has been shown to be effective for carpal tunnel syndrome and premenstrual syndrome. Experimental evidence reveals that Vitamin B6 favourably affects prostaglandin synthesis increasing anti-inflammatory prostaglandin 1 and 3 (PG1 and PG3), and helping to decrease pro-inflammatory PG2.

The main biochemical interventions appear to be increasing the activity of delta-6-desaturase enzyme, which increases the conversion of alpha-linolenic acid to EPA and DHA. EPA can be converted to PG3, exerting an anti-inflammatory effect.

Typical daily dosage to control inflammatory conditions ranges from 25-100 mg.5-13 It seems plausible that Vitamin B6 supplementation can be used to help control all inflammatory conditions mediated by prostaglandin synthesis.

Autism and Attention Deficit Hyperactivity Disorder

A number of clinical trials and experimental evidence suggests that Vitamin B6 may be part of adjunctive treatment to help in these childhood conditions. Only about 20 percent of subjects may show moderate improvement and 10 percent more dramatic improvement with Vitamin B6 supplementation. Vitamin B6 is the coenzyme for brain decarboxylation enzymes, helping to synthesize dopamine, GABA, and serotonin which appear to be involved in these disorders. In this regard, Vitamin B6 appears to work best in conjunction with magnesium supplementation. The usual dosage is 25-50 mg of Vitamin B6 and 200 mg of magnesium per day.14-27

Depression (secondary to birth control pill and hormone replacement therapy)

Vitamin B6 levels are often low in females taking birth control pills or Premarin. Supplementation with 50-100 mg of Vitamin B6 per day has been shown to help reverse the depression that may result from taking these drugs.28-31

Asthma

Double-blind clinical studies show that some patients with asthma benefit from Vitamin B6 supplementation (50 mg twice daily) to correct defects in tryptophan and serotonin metabolism. Also, the asthmatic drug theophylline decreases pyridoxal-5-phosphate levels, and B6 supplementation reduces theophylline-induced side effects (headache, nausea, irritability, sleep disorders).32-35

Childhood Seizures, Tardive Dyskinesia and Epilepsy

A number of clinical trials reveal that Vitamin B6 supplementation at 50-100 mg per day may be helpful for these conditions. Be aware that doses over 80 mg may interfere with anticonvulsant therapy in epileptics.36-39

Diabetic Neuropathy

Vitamin B6 supplementation has been shown to improve diabetic neuropathy and inhibit the glycosylation of proteins, a key prognostic indicator of diabetic control and risk of complications.40,41 50-100 mg per day may be useful in this regard.

Kidney Stones

Vitamin B6 supplementation has been shown to help prevent recurrence of calcium oxalate kidney stones. This effect is best by combining B6 and magnesium supplementation. 50-100 mg of Vitamin B6 (up to 300 mg) and 200-300 mg magnesium.42,43

Vitamin B6 Toxicity

Neurotoxicity from excess Vitamin B6 intake can occur at doses as low as 100-150 mg per day, take over many months. Signs and symptoms of neurotoxicity include:

Tingling sensation in feet
Loss of muscle coordination
Degeneration of nerve tissue

Therefore, it is best to limit Vitamin B6 supplementation to 50 mg. In some instances it can be taken up to 100 mg per day in divided doses.44-47

Drug-Nutrient Interactions

  1. Levodopa
    Vitamin B6 may increase the breakdown of levodopa, possibly altering the drug’s effectiveness in Parkinson’s patients. However, the use of a drug combining levodopa with carbidopa (Sinemet) is reported to avoid this potential problem.48
  2. The following drugs are reported to cause Vitamin B6depletion:
    Antibiotics-decrease B-vitamin synthesis by bacterial flora.49,50
    Oral contraceptives and Hormone Replacement Therapy (estrogen-containing drugs).51
    Hydralazine.52,53
    Loop Diuretics - cause increased urinary loss of Vitamin B654
    Isoniazid55,56,57
    Penicillamine58,59,60
    Phenelzine61
    Theophylline - decrease the active form of Vitamin B662

Pregnancy and Lactation

1. During pregnancy and lactation, the only supplements that are considered safe include standard prenatal vitamin and mineral supplements. All other supplements or dose alterations may pose a threat to the developing fetus and there is generally insufficient evidence at this time to determine an absolute level of safety for most dietary supplements other than a prenatal supplement. Any supplementation practices beyond a prenatal supplement should involve the cooperation of the attending physician (i.e., magnesium and the treatment of preeclampsia.)

References: Pregnancy and Lactation

  1. Encyclopedia of nutritional supplements. Murray M. Prima Publishing 1998.
  2. Reavley N.M. The new encyclopedia of vitamins, minerals, supplements, and herbs. Evans and Company Inc. 1998.
  3. The Healing Power of Herbs (2nd ed). Murray M. Prima Publishing 1995.
  4. Boon H. and Smith M. Health care professional training Program in complementary medicine. Institute of Applied Complementary Medicine Inc. 1997.

Standard Textbooks of Nutritional Science:

- Shils M, Shike M, Olson J, Ross C. Modern Nutrition in Health and Disease. 9th ed. Baltimore, MD: Lippincott Williams & Wilkins; 1993.

- Escott-Stump S, Mahan LK, editors. Food, Nutrition and Diet Therapy. 10th ed. Philadelphia, PA: W.B. Saunders Company; 2000.

- Bowman B, Russell RM, editors. Present Knowledge in Nutrition, 8th ed. Washington, DC:.ILSI Press; 2001.

- Kreutler PA, Czajka-Narins DM, editors. Nutrition in Perspective. 2nd ed. Upper Saddle River, NJ: Prentice Hall Inc.; 1987.

Van der Griend R, Haas FJ, Biesma DH, Haas FJ, Faber JA, Duran M, et al. Combination of low-dose folic acid and pyridoxine for treatment of hyperhomocysteinaemia in patients with premature arterial disease and their relatives. Atherosclerosis 1999;143:177-83.

Lam SCT, Harfenist EJ, Packham MA, Mustard JF. Investigation of possible mechanisms of pyrodoxal 5-phosphate inhibition of platelet reactions. Thrombosis Res 1980;20:633-45.

Sermet A, Aybak M, Ulak G, Güzel C, Denli O. Effect of oral Pyridoxine hydrochloride supplementation on in vitro platelet sensitivity to different agonists. Arzneim Forsch 1995;45:19-21.

Tsuge H, Hotta N, Hayakawa T. Effects of vitamin B6 on (n-3) polyunsaturated fatty acid metabolism. J Nutr 2000;130(2):333-4.

Ellis JM, Folkers K, Levy M, Shizukuishi S, Lewandowski J, Nishii S, et al. Response of vVitamin B6 deficiency and the carpal tunnel syndrome to pyrosoxine. Proc Natl Acad Sci USA 1982;79:7494-8.

Folkers K, Ellis J. Successful therapy with Vitamin B6 and Vitamin B2 of the carpal tunnel syndrome and need and determination of the RDA’s for vitamin B6 and B2 disease states. Annals NY Acad Sci 1990;585:295-301.

Ellis JM, et al. Clinical aspects of treatment of carpal tunnel syndrome with vitamin B6. Annals NY Acad Sci 1990;585:302-20.

Phalen GS. The birth of a syndrome, or carpal tunnel syndrome revisited. J Hand Surg 1981 ;6:109-10.

Berman MK, Taylor ML, Freeman E. Vitamin B6 in premenstrual syndrome. J. Am Diet Assoc 1990;90:859-61.

Kliejnen J, Ter Riet G, Knipschild P. Vitamin B6 in the treatment of premenstrual syndrome-a review. Br J Obstet Gynaecol 1990;97:847-52.

Barr W. Pyridoxine supplements in the premenstrual syndrome. Practitioner 1984;228:425-7.

Snider B, Dietman DF. Pyridoxine therapy for premenstrual acne flare. Arch Dermatol 1974; 110:130-31.

Rimland B, et al. The effect of high doses of vitamin B6 on autistic children. A double-blind cross-over study. Am J Psychiatry 1978;135:422.

Lelard G, et al. Electrophysiological and biochemical studies in autistic children treated with vitamin B6. In: Lehmann D, Callaway E. Human Evoked Potentials: Applications and Problems. New York: Plenum Press; 1970.

Lelard G, et al. Modifications in urinary homovanillic acid after ingestion of Vitamin B6: functional study in autistic children. Rev Neuro 1978; 134(12):797-801.

Coleman M, et al. A preliminary study of the effect of Pyridoxine administration in a subgroup of hyperkinetic children: a double-blind crossover comparison with methylphnidate. J Biol Psych 1979;14(5):741-51.

Martineau J, et al. Vitamin B6, Magnesium, and combined B6-mg; therapeutic effects in childhood autism. Biol Psychiat 1985;20:467-78.

Martineau J, et al. Effects of Vitamin B6 on averaged evoked potentials in infantile autism. Bio Psychiat 1981 ;16:627-41.

Kozielec T, et al. Assessment of Magnesium levels in children with attention deficit hyperactivity disorder (ADHD). Magnes Res 1997; 10(2): 143-8.

Starobrat B, Hermelin, et al. The effects of Magnesium physiological supplementation on hyperactivity in children with ADHD. Positive response to magnesium oral loading test. Magnes Res 1997;10(2)149-56.

Hawkins D. Orthomolecular psychiatry: treatment of schizophrenia. In: Hawkins D, Pauling L, editors. Orthomolecular Psychiatry. San Francisco: WH Freeman and Company; 1973.

Brenner A. The effects of megadoses of selected B-complex vitamins on children with hyperkinesis: controlled studies with long-term follow-up. J Learning Disabl 1982;15:258.

Hoffer A. Vitamin B3 dependent child. Schizophrenia 1971;3:107-13.

Thiessen I, et al. The use of megavitamin treatment in children with learning disabilities. J Orthomol Psychiat 1975;4(4):288-96.

Hoffer A, et al. Treatment of schizophrenia with Nicotinic Acid. Acta Psych Scand 1964;40(2):171-89.

Hoffer A. The effect of Nicotinic Acid on the frequency and duration of rehospitalization of schizophrenic patients, a controlled comparison study. Int J Neuropsych 1966;2(3):234-40.

Nobbs B. Pyridoxal Phosphate status in clinical depression. Lancet 1974;1:405.

Bermond P. Therapy of side effects of oral contraceptive agents with Vitamin B6. Acta Vitaminol-Enzymol 1982;4:45-54.

Adams PW, et al. Effect of Pyridoxine hydrochloride (vitamin B6) upon depression associated with oral contraception. Lancet 1973;1:897-904.

Russ CS, et al. Vitamin B6 status of depressed and obsessive-compulsive patients. Nutr Rep Internat 1983;27:867-73.

Collip PJ, et al. Pyridoxine treatment of childhood asthma. Ann Allergy 1975; 35:93-7.

Reynolds RD, et al. Depressed plasma pyridoxal-5-phosphate concentrations in adult asthmatics. Am J Clin Nutr 1985;43:684-8.

Shimizu T, et al. Theophylline attenuates circulating vitamin B6 levels in children with asthma. Pharmacol 1994;49:392-7.

Bartel PR, et al. Vitamin B6 supplementation and theophylline-related effects in humans. Am J Clin Nutr 1994; 60:93-9.

Murray MT. Encyclopedia of Nutritional Supplements. Prima Publishing; 1996.

Baxter P. Epidemiology of Pyridoxine dependent and Pyridoxine responsive seizures in the U.K. Arch Dis Child 1999; 81 (5):431-3.

Toshikawa H. Pyridoxine-dependent seizures in an older child. J Child Neural 1999;14(10):687-90.

Lerner V, et al. Vitamin B6 in treatment of tardive Dyskinesia: a preliminary case series study. Clin Neuropharmacol 1999; 22(4):241-3.

Jones CL, et al. Pyridoxine deficiency: a new factor in diabetic neuropathy. J Am Pod Assoc 1978; 68:646-53.

Solomon LR, et al. Erythrocyte, transport and metabolism and effects of Vitamin B6 therapy in type II diabetes mellitus. Diabetes 1989;38:881-6.

Murthy M , et al. Effect of Pyridoxine supplementation on recurrent stone formers. Int J Clin Pharm Ther Tox 1982;20:434-7.

Azowry L, et al. May enzyme activity in urine play a role in kidney stone formation? Urol Res 1982;10:185-9.

Cohen M, et al. Safety of Pyridoxine-a review of human and animal studies. Toxicol Letters 1986;34:129-39.

Parry GJ, et al. Sensory neuropathy with low-dose Pyridoxine. Neurology 1985;35:1466-8. Waterston JA Pyridoxine Neuropathy. Med J Aust 1987;146:640-2.

Dalton K, et al. Characteristics of Pyridoxine overdose neuropathy syndrome. Act Neurol Scand 1987;76:8.

Boshes B. Sinemet and the Treatment of Parkinsonism. Ann Intern Med 1981 ;94(3):364-70.

Cummings JH, Macfarlane G. Role of intestinal bacteria in nutrient metabolism. J Parenter Enteral Nutr 1997;21 (6):357-65.

Deguchi Y, Morishita T, Mutai M. Comparative studies on synthesis of water-soluble vitamins among species of bifidobacteria. Agric Biol Chem 1985;49(1):13-9.

Haspels AA, et al. Disturbance of tryptophan metabolism and its correction during oestrogen treatment in postmenopausal women. Maturitas 1978;1(1):15-20.

Vidrio H. Interaction with Pyridoxal as a possible mechanism of hydralazine hypotension. J Cardiovasc Pharmacol 1990;15(1):150-6.

Shigetomi S, Kuchel O. Defective 3,4-dihydroxyphenylalanine decarboxylation to dopamine in hydralazine-treated hypertensive patients may be pyridoxine remediable. Am J Hypertens 1993;6(1):33-40.

Mydlik M, Derzsiova K, Zemberova E. Influence of water and sodium diuresis and furosemide on urinary excretion of Vitamin B6, Oxalic Acid and Vitamin C in chronic renal failure. Miner Electrolyte Metab. 1999;25(4-6):352-6.

Matsui MS, Fozovski SJ. Drug-nutrient interaction. Clin Ther 1982;4(6):423-40.

Snider DE Jr. Pyridoxine supplementation during isoniazid therapy. Tubercle 1980;61 (4):191-6.

Siskind MS, Thienemann D, Kirlin L. Isoniazid-induced neurotoxicity in chronic dialysis patients: report of three cases and a review of the literature. Nephron 1993;64(2):303-6.

Seelig MS. Auto-immune complications of d-penicillamine-a possible result of Zinc and Magnesium depletion and of Pyridoxine inactivation. J Am Coll Nutr 1982;1 (2):207-14.

Jaffe IA. Antivitamin B6 effect of d-penicillamine. In Vitamin B6 in metabolism or the nervous system. Ann N.Y. Acad Sci 1969;166:57-60.

Yamada R. Antivitamin B6 activity of l-penicillamine in Escherichia coli. Acta Vitaminol Enzymol 1983;5(2):73-81.

Steward JW, et al. Phenelzine-induced pyridoxine deficiency. J Clin Psychopharmacol. 1984;4(4):225-6.

Ubbink JB, et al. Evidence of a theophylline-induced vitamin B6 deficiency caused by non-competitive inhibition of pyridoxal kinase. J Lab Clin Med 1989;113(1):15-22.